Comparative thromboembolic risk in atrial fibrillation patients with and without a concurrent infection

Anna Gundlund, Thomas Kümler, Jonas Bjerring Olesen, Anders Nissen Bonde, Gunnar H Gislason, Christian Torp-Pedersen, Lars Køber, Emil Loldrup Fosbøl

Research output: Contribution to journalJournal articleResearchpeer-review

5 Citations (Scopus)
92 Downloads (Pure)

Abstract

BACKGROUND: The aim of this study was to compare long-term thromboembolic risk in infection-related and non-infection-related atrial fibrillation (AF).

METHODS: Using Danish nationwide registries, we identified patients with first-time AF from 1996-2015 and performed a retrospective cohort study. We did a 1:1 match (upon sex, age, calendar year, and oral anticoagulation (OAC) status at the beginning of follow-up) of patients with infection-related (concurrent discharge diagnosis code for infection) and non-infection-related AF. Long-term outcomes were examined using multivariable Cox regression analyses.

RESULTS: Our study population comprised 48,644 patients equally distributed on infection-related and non-infection-related AF. In both groups, those initiated on OAC therapy were younger than those not initiated on OAC therapy (median age 77 years, interquartile range 69-83 versus median age 79 years, interquartile range 71-86). During the 1st year of follow up, infection-related AF was associated with an increased risk of thromboembolic events compared with non-infection-related AF: adjusted hazard ratio (HR) 1.44 (95% confidence interval (CI) 1.16-1.78) for those initiated on OAC therapy and HR 1.17 (95% CI 1.06-1.28) for those not initiated on OAC therapy. In both groups, OAC therapy was associated with better outcomes than no OAC therapy (HR of thromboembolic events 0.75 (95% CI 0.68-0.83) and HR 0.70 (95% CI 0.63-0.78) for patients with infection-related and non-infection-related AF, respectively).

CONCLUSION: Infection was associated with an increased thromboembolic risk in patients with first-time AF. OAC therapy was associated with a similar risk-reduction in AF patients with and without a concurrent infection.

Original languageEnglish
JournalAmerican Heart Journal
Volume204
Pages (from-to)43-51
Number of pages9
ISSN0002-8703
DOIs
Publication statusPublished - 1 Oct 2018

Fingerprint

Dive into the research topics of 'Comparative thromboembolic risk in atrial fibrillation patients with and without a concurrent infection'. Together they form a unique fingerprint.

Cite this